Abstract P2-06-02: Development of a first-in-class small molecule inhibitor (EC359) targeting oncogenic LIF/LIFR signaling for the treatment of triple negative breast cancer
Viswanadhapalli, S, Luo, Y, Sareddy, GR, Santhamma, B, Zhou, M, Li, M, Pratap, UP, Altwegg, KA, Li, X, Srinivasan, U, Ma, S, Chang, A, Riveros, AC, Zhang, KY, Dileep, KV, Pan, X, Murali, R, Bajda, M, Raj, G, Brenner, A, Manthati, V, Rao, M, Tekmal, RR, Nair, HB, Nickisch, KJ, Vadlamudi, RK
Published in Cancer research (Chicago, Ill.) (15.02.2019)
Published in Cancer research (Chicago, Ill.) (15.02.2019)
Get full text
Journal Article
Neuroprotective derivatives of tacrine that target NMDA receptor and acetyl cholinesterase - Design, synthesis and biological evaluation
Chandran Remya, Kv Dileep, Eeda Koti Reddy, Kumar Mantosh, Kesavan Lakshmi, Jacob, Reena Sarah, Sajith, Ayyiliyath M, Variyar, Ejayadevi, Shaik Anwar, Zhang, Kam Y J, Sadasivan, C, Omkumar, R V
Published in bioRxiv (19.01.2021)
Published in bioRxiv (19.01.2021)
Get full text
Paper